Tradename | Company | Number | Date | Products |
---|---|---|---|---|
KONVOMEP | Azurity | N-213593 RX | 2022-08-30 | 1 products, RLD, RS |
ZEGERID OTC | Riley Consumer Care Holdings | N-022281 OTC | 2009-12-01 | 1 products, RLD, RS |
ZEGERID OTC | Riley Consumer Care Holdings | N-022283 OTC | 2013-06-17 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OMEPRAZOLE | Dexcel Pharma | N-209400 OTC | 2017-07-05 | 1 products, RLD, RS |
OMEPRAZOLE | Dexcel Pharma | N-022032 OTC | 2007-12-04 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
YOSPRALA | Genus Lifesciences | N-205103 DISCN | 2016-09-14 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
OMECLAMOX-PAK | Cumberland Pharmaceuticals | N-050824 DISCN | 2011-02-08 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TALICIA | RedHill Biopharma | N-213004 RX | 2019-11-01 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PRILOSEC OTC | AstraZeneca | N-021229 OTC | 2003-06-20 | 1 products, RLD, RS |
PRILOSEC | Covis Pharma | N-022056 RX | 2008-03-20 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
24 hr omeprazole | New Drug Application | 2022-06-01 |
acid reducer | ANDA | 2024-08-15 |
amazon basic care omeprazole | ANDA | 2024-05-10 |
aspirin and omeprazole delayed-release tab | New Drug Application | 2019-11-20 |
basic care omeprazole | ANDA | 2024-09-05 |
basic care omeprazole and sodium bicarbonate | ANDA | 2021-07-22 |
berkley and jensen omeprazole | New Drug Application | 2023-06-28 |
care one omeprazole | New Drug Application | 2019-05-20 |
careone omeprazole | New Drug Application | 2022-06-07 |
caring mill omeprazole | New Drug Application | 2021-10-08 |
Expiration | Code | ||
---|---|---|---|
AMOXICILLIN / OMEPRAZOLE MAGNESIUM / RIFABUTIN, TALICIA, REDHILL | |||
2027-11-01 | GAIN | ||
2022-11-01 | NP |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Amoxicillin / Omeprazole Magnesium / Rifabutin, Talicia, Redhill | |||
11878011 | 2042-05-27 | U-3816 | |
9050263 | 2034-02-12 | DP | U-2660 |
9498445 | 2034-02-12 | DP | U-2660 |
9603806 | 2034-02-12 | DP | U-2660 |
10238606 | 2034-02-12 | DP | |
11135172 | 2034-02-12 | DP | U-2660 |
Omeprazole / Sodium Bicarbonate, Konvomep, Azurity | |||
11771686 | 2040-03-01 | U-623 | |
10751333 | 2039-07-16 | DP | |
11103492 | 2039-07-16 | DP | |
11633478 | 2039-07-16 | DP | |
Omeprazole, Omeprazole, Dexcel | |||
10076494 | 2036-12-08 | DP | |
10835488 | 2036-12-08 | DP | |
Aspirin / Omeprazole, Yosprala, Genus Lifesciences | |||
9539214 | 2033-03-13 | U-1902 | |
9987231 | 2033-01-02 | U-2324 | |
Omeprazole, Omeprazole, Dexcel Pharma | |||
9023391 | 2025-08-16 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 137 | — | 1 | 6 | 6 | 150 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 17 | 20 | 29 | 40 | 27 | 127 |
Infections | D007239 | EFO_0000544 | — | 9 | 6 | 12 | 32 | 18 | 72 |
Ulcer | D014456 | MPATH_579 | — | 6 | 4 | 19 | 13 | 6 | 47 |
Helicobacter infections | D016481 | EFO_1000961 | — | 2 | 2 | 8 | 15 | 11 | 37 |
Peptic esophagitis | D004942 | EFO_1001095 | — | 3 | 6 | 11 | 9 | 8 | 36 |
Dyspepsia | D004415 | EFO_0008533 | K30 | 4 | 6 | 7 | 13 | 6 | 34 |
Esophagitis | D004941 | HP_0100633 | K20 | 4 | 4 | 11 | 9 | 6 | 33 |
Peptic ulcer | D010437 | HP_0004398 | K27 | 3 | 1 | 7 | 17 | 4 | 32 |
Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 2 | 11 | 12 | 3 | 29 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 6 | 2 | 2 | — | 1 | 10 |
Gastrointestinal diseases | D005767 | — | — | 2 | 1 | 2 | — | 3 | 7 |
Digestive system diseases | D004066 | HP_0011024 | K92.9 | 1 | — | 2 | — | 3 | 6 |
Sclerosis | D012598 | — | — | 1 | — | 2 | — | — | 3 |
Gastrinoma | D015408 | — | — | — | 1 | 1 | — | 1 | 3 |
Zollinger-ellison syndrome | D015043 | — | E16.4 | — | 1 | 1 | — | 1 | 3 |
Pancreatitis | D010195 | HP_0001733 | K85 | 1 | — | 1 | — | 1 | 3 |
Asthma | D001249 | EFO_0000270 | J45 | — | 2 | 1 | — | — | 3 |
Human experimentation | D006805 | — | — | — | — | 3 | — | — | 3 |
Exocrine pancreatic insufficiency | D010188 | — | K86.81 | — | 1 | 1 | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 19 | 2 | — | — | — | 21 |
Lymphoma | D008223 | — | C85.9 | 3 | 2 | — | — | 2 | 7 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 6 | — | — | — | 6 |
Fatty liver | D005234 | EFO_0003934 | — | — | 6 | — | — | — | 6 |
Hepatitis c | D006526 | — | B19.2 | 5 | 1 | — | — | — | 6 |
Prostatic neoplasms | D011471 | — | C61 | 3 | 1 | — | — | 1 | 5 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 4 | 1 | — | — | — | 5 |
Dermatitis | D003872 | HP_0011123 | L30.9 | 4 | 1 | — | — | — | 5 |
Liver diseases | D008107 | HP_0002910 | K70-K77 | — | 4 | — | — | — | 4 |
Eczema | D004485 | HP_0000964 | L30.9 | 3 | 1 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 6 | — | — | — | — | 6 |
Psoriasis | D011565 | EFO_0000676 | L40 | 5 | — | — | — | — | 5 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | 3 | 4 |
Covid-19 | D000086382 | — | — | 1 | — | — | — | 3 | 4 |
Pharmacokinetics | D010599 | — | — | 4 | — | — | — | — | 4 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | — | — | — | 1 | 3 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 3 | — | — | — | — | 3 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 3 | — | — | — | — | 3 |
Melanoma | D008545 | — | — | 2 | — | — | — | — | 2 |
Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Purpura | D011693 | HP_0000979 | D69.2 | — | — | — | — | 2 | 2 |
Vasovagal syncope | D019462 | — | R55 | — | — | — | — | 2 | 2 |
Syncope | D013575 | HP_0012668 | G90.01 | — | — | — | — | 2 | 2 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | — | — | — | 1 | 1 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | — | — | — | 1 | 1 |
Pneumonia | D011014 | EFO_0003106 | — | — | — | — | — | 1 | 1 |
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | — | — | — | — | 1 | 1 |
Pyloromyotomy | D000074882 | — | — | — | — | — | — | 1 | 1 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 1 | 1 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 1 | 1 |
Drug common name | Omeprazole |
INN | omeprazole |
Description | 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole is a member of benzimidazoles and a sulfoxide. |
Classification | Small molecule |
Drug class | antiulcer agents (benzimidazole derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1 |
PDB | — |
CAS-ID | 73590-58-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1503 |
ChEBI ID | 77260 |
PubChem CID | 4594 |
DrugBank | DB00338 |
UNII ID | KG60484QX9 (ChemIDplus, GSRS) |